CHRISTOPHER LEDBETTER: Open Payments
NPI 1386277028 · WAXAHACHIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 29 payments from 6 companies in 2025. Trend: 2023 $226 · 2024 $221 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $316 |
| Braintree Laboratories, Inc. | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: CREON, RINVOQ, SUFLAVE, SKYRIZI, ENTYVIO, IQIRVO, ZENPEP, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
